English Russian Japan
Diabetes

Reviews

John

Great product, original Japanese Lactis EL027826792JP
more ▶

Reviews

Mike

Good effect. I shall order again. Original made-in-japan package as promised EG401137451JP
more ▶

Reviews

May

Real Japanese laennec. Thank you! I shall order again. EJ377189782JP
more ▶

Reviews

Bob

Great effect! Got my hair back in 3 months. EG401137588JP
more ▶

Reviews

Nike

Lost 3 kilos since started to drink it last month. Great for fitness EG299855913JP
more ▶

Reviews

Any

Bought it for my son. Good effect and great service. EG299855961JP
more ▶

Reviews

Nya

Original touchi, fast delivery and good price. Thank you. EG401137156JP
more ▶

Reviews

Sam

Good medicine. Think it really helps me to fight cancer. EL025661542JP
more ▶

Reviews

John

3 times cheaper than in our country! And great effect for knees EJ365886698JP
more ▶

Reviews

Mike

Great thing to support diet. Lost 4 kilos for 6 weeks. Shall order more EJ365886675JP
more ▶
Home Disorders Diabetes
Deberza tablets 20 mg for type 2 diabetes (tofogliflozin hydrate, CSG452, Apleway)
Deberza tablets 20 mg for type 2 diabetes (tofogliflozin hydrate, CSG452, Apleway)
Deberza tablets 20 mg for type 2 diabetes (tofogliflozin hydrate, CSG452, Apleway)
Product Code Deberza
Availability 5
Price USD 589.00
Qty
Buy now Guarantee Contact as

Deberza tablets 20 mg for type 2 diabetes (tofogliflozin hydrate, CSG452, Apleway)

Product Code : Deberza

Availability : 5

USD 589.00

Buy now

General information on Japanese Deberza tablets 20 mg from Japan for type 2 diabetes (tofogliflozin hydrate, CSG452, Apleway)

Package details: 100 tablets

Manufacturer: Kowa Co., Ltd., Japan

Active ingredients: tofogliflozin hydrate (chemical formula C22H28O7)

Medical effect: Deberza tablets are effective for the treatment of type 2 diabetes mellitus.

Contraindications and precautions: do not use for the following categories of patients:

  • pregnant or breastfeeding women,
  • patients with ketosis, diabetic coma or precoma,
  • patients with infection or injury,
  • patients in the pre-/post-operative period.

As this medicine may cause hypoglycemia, patient should take care when working at heights, operating dangerous machinery or driving a car.

If hypoglycemic symptoms occur while patient is taking this medicine concomitantly with an alpha-glucosidase inhibitor (acarbose, voglibose, etc.), patient should take the glucose. It’s recommended to carry sugar or glucose to use in case of hypoglycemia and to carry a card of diabetic patient.

In some rare cases this medicine may cause urinary-tract infection or genital infection. Patient should pay attention to the unusual symptoms and consult with the doctor if needed.

As this medicine may cause frequent urination, patients should drink an adequate amount of fluid and pay attention to excessive decrease in body weight.

If an allergic reaction occurs, stop using the medicine and consult with your doctor. If you’re taking any other medication or receiving any other treatment, you have to consult with your doctor before use.

Dosage and administration

For adults: take 1 tablet (20 mg of active ingredient) once a day, before or after breakfast.

How effective are Deberza tablets 20 mg from Japan for type 2 diabetes (tofogliflozin hydrate, CSG452, Apleway)?

Deberza tablets contain tofogliflozin hydrate, a highly specific sodium/glucose cotransporter inhibitor. It works by inhibiting high glucose-induced reactive oxygen species generation in tubular cells and consequently inhibiting glucose reabsorption in kidneys. By this, Deberza tablets promote the excretion of glucose into urine and decrease the blood sugar level.

Who should use Deberza tablets 20 mg from Japan?

Deberza tablets are effective for the treatment of type 2 diabetes mellitus. Studies showed that the course of treatment with tofogliflozin for the 52 weeks was safe for patients, generally well-tolerated, and effective both when used solely or together with other antidiabetic medicines like acarbose or voglibose (Y. Tanizawa, K. Kaku et al. Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials // Expert opinion on pharmacotherapy. 2014, 15(6): 749-66).

There are no reviews for this product.

Write a review

Rating Bad           Good


News

Unknown Deposits

Dear Customers!   IF YOU PAID BY WISE COM before MAY 3rd   AND STILL DID NOT RECEIVE PAYMENT CONFIRMATION FROM US -   Please contact us by email and advise Exact payout amount in EURO.   Our bank had a disruption during holidays, we can not see comments and references, we only see “WISE” and Amount in EURO for all payment received during holidays.   THE LIST OF SIX TRANSACTIONS IS BELOW:   237.90 EUR - APRIL 27th 924.20 EUR - APRIL 27th   236.17 EUR - APRIL 28th 189.20 EUR - APRIL 28th   272.34 EUR - MAY 5th   224.15 EUR - MAY 10th   Please kindly assist if you paid and help to identify payments.   Sincerely yours Japan Health Centre
more ▶

Reviews

John

Great product, original Japanese Lactis EL027826792JP
more ▶

Reviews

Mike

Good effect. I shall order again. Original made-in-japan package as promised EG401137451JP
more ▶

Reviews

May

Real Japanese laennec. Thank you! I shall order again. EJ377189782JP
more ▶

Reviews

Bob

Great effect! Got my hair back in 3 months. EG401137588JP
more ▶

Reviews

Nike

Lost 3 kilos since started to drink it last month. Great for fitness EG299855913JP
more ▶

Reviews

Any

Bought it for my son. Good effect and great service. EG299855961JP
more ▶

Reviews

Nya

Original touchi, fast delivery and good price. Thank you. EG401137156JP
more ▶

Reviews

Sam

Good medicine. Think it really helps me to fight cancer. EL025661542JP
more ▶

Reviews

John

3 times cheaper than in our country! And great effect for knees EJ365886698JP
more ▶

Reviews

Mike

Great thing to support diet. Lost 4 kilos for 6 weeks. Shall order more EJ365886675JP
more ▶